HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
|HTG Molecular Presentation Details|
|Thursday, February 28
3:00pm Eastern Time
Lotte New York Palace Hotel
HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options.
LifeSci Advisors, LLC
Phone: (617) 535-7742
Chief Financial Officer
Source: HTG Molecular Diagnostics, Inc.